International Stem Cell
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. International Stem Cell's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 5% to $7,789,000. The net income raised on -$131,000 and profit margin reached -2%. Total operating expenses were $5,271,000.

Profit Margin

International Stem Cell Corporation (OTC:ISCO): Profit margin
2014 7.01M -12.47M -177.83%
2015 7.55M -2.63M -34.9%
2016 7.16M -1.07M -15.06%
2017 7.45M -6.06M -81.4%
2018 11.08M -2.13M -19.22%
2019 9.47M -4.34M -45.86%
2020 7.12M -2.83M -39.8%
2021 7.17M -1.04M -14.49%
2022 8.18M -466K -5.7%
2023 7.78M -131K -1.68%

ISCO Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
7.78M8.18M7.17M7.12M9.47M11.08M7.45M7.16M7.55M7.01M
Cost of revenue
3.18M3.26M2.93M2.78M3.93M4.06M2.12M1.94M2.05M1.92M
Gross profit
4.60M4.91M4.24M4.34M5.53M7.02M5.33M5.22M5.49M5.09M
Operating exp.
Research and development
511K492K695K988K1.38M2.39M2.65M2.85M2.70M5.38M
Selling and marketing
1.24M1.24M1.38M1.75M2.68M2.63M2.40M2.52M2.63M2.78M
Total operating expenses
5.27M5.09M6.16M7.16M11.26M10.49M10.27M10.07M10.05M13.77M
Operating income
-663K-196K-1.92M-2.81M-5.72M-3.47M-4.94M-4.85M-4.56M-8.68M
Other income (expenses), net
532K-135K1.02M94K1.46M1.39M-1.12M4.70M1.92M-3.79M
Income before tax
-131K-331K-899K-2.72M-4.26M-2.13M-6.06M-1.07M-2.63M-12.47M
Income tax expense
0135K141K113K79K1.39M59K6K11K2K
Net income
-131K-466K-1.04M-2.83M-4.34M-2.13M-6.06M-1.07M-2.63M-12.47M
Earnings per share
Basic EPS
-0.01-0.05-0.13-0.38-0.58-0.33-1.46-0.34-1.33-9.71
Diluted EPS
-0.01-0.05-0.13-0.38-0.58-0.33-1.46-0.34-1.29-9.71
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source